4197.TWO Visgeneer

Healthcare Health Care Equipment & Supplies Taiwan OTC Exchange
7.35 TWD
Close of Nov 6, 2026
7.30 22.50
Market cap
TWD 222M
P/E
-
P/B
1.26x
ROE
2.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 4197.TWO undervalued?

Graham number

The Graham number of Visgeneer cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Visgeneer fundamental analysis

No fundamental analysis for Visgeneer yet.

Visgeneer stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Visgeneer

Visgeneer Inc. engages in the provision of health solutions in the fields of medical device, cosmetics and skin care, Zeaxanthin, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; face cream, night cream, day cream, wrinkle cream, repairing cream, whitening cre…

Full company profile